More Algorae Pharmaceuticals Limited news
Algorae Pharmaceuticals LimitedASX: 1AI

Algorae Pharmaceuticals: Half Year Report and Appendix 4D

Feb 27, 2026 at 3:22 AM EST · Issued by Algorae Pharmaceuticals Limited

Filed with ASX · Feb 27, 2026 at 3:22 AM EST

On 6ix: 6ix.com/news/half-year-report-and-appendix-4d-9

Algorae Pharmaceuticals Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Algorae Pharmaceuticals Limited on 6ix

Story so far

  • Quarterly Activities Report /Appendix 4C Cash Flow StatementJan 28, 2026
  • Annual Report and Appendix 4EAug 28, 2025
  • Half Yearly Report Announcement and Appendix 4DFeb 26, 2025

Earlier from Algorae Pharmaceuticals

  • Algorae Signs License and Supply Agreement with CadilaFeb 8
  • Quarterly Activities Report /Appendix 4C Cash Flow StatementJan 27
  • $3 million Debt Facility Secured with ScotPacJan 20
  • AlgoraeOS v2 Identifies 90 Drug Combination CandidatesDec 11, 2025
  • Algorae Receives $384,466.78 R&D Tax Incentive RefundDec 9, 2025

Later from Algorae Pharmaceuticals

  • Peter Mac Partners with Algorae on AI ValidationMar 29
  • TGA Accepts Initial Registration Dossier for EvaluationApr 1
  • Algorae Pharmaceuticals Ltd Raises $3.9mApr 2
  • Algorae and Zydus Enter Exclusive Commercial AgreementApr 27
  • 1AI Executes License & Supply Agreement with Torrent PharmaMay 5
All Algorae Pharmaceuticals news releases↗

Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.

Follow Algorae Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer